CMV infection
Clinical trials for CMV infection explained in plain language.
Never miss a new study
Get alerted when new CMV infection trials appear
Sign up with your email to follow new studies for CMV infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Malaria drug could help fight dangerous virus in transplant patients
Disease control Recruiting nowThis study tests whether adding the malaria drug artesunate to standard antiviral treatment can better control cytomegalovirus (CMV) infection in people who have received a solid organ transplant (kidney, lung, heart, or liver). About 90 adult participants will receive either a l…
Matched conditions: CMV INFECTION
Phase 2 • Sponsor: Amivas Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Immune cells engineered to hunt viruses show promise for transplant kids
Disease control Recruiting nowThis study tests a new cell therapy called LB-DTK-MV in children aged 1-25 who have stubborn viral infections (CMV, EBV, or BKV) after a stem cell transplant. The therapy uses specially grown immune cells from a donor to attack the viruses. Participants receive two infusions two …
Matched conditions: CMV INFECTION
Sponsor: LucasBio • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Donor cells take on Drug-Resistant viruses in new trial
Disease control Recruiting nowThis early-phase trial tests a treatment called LB-DTK-MV, which uses immune cells from a healthy donor to fight three viruses (CMV, BKV, and EBV) that have become resistant to standard antiviral drugs. The study includes 27 adults who have had a stem cell transplant or certain c…
Matched conditions: CMV INFECTION
Phase 1/2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC